← Clinical Evidence

SRC-9d3202d37ff7 Matinolli M 2011

Evidence source and scope

Matinolli M, Korpelainen JT, Sotaniemi KA, Myllylä VV, Korpelainen R. Recurrent falls and mortality in Parkinson’s disease: a prospective two-year follow-up study. Acta Neurologica Scandinavica. 2011;123:193–200. DOI 10.1111/j.1600-0404.2010.01386.x

This note indexes a cited or audit-added source. It may be an original study, review, guideline, form or methods reference. Treat the specific design and the evidence below as authoritative; a source note is not automatically a primary study.

DOI: 10.1111/j.1600-0404.2010.01386.x

Bibliographic record from the original reports

Access labels embedded in these original reference strings are historical. Current access and exact checked components are stated separately below.

Matinolli M, Korpelainen JT, Sotaniemi KA, Myllylä VV, Korpelainen R. Recurrent falls and mortality in Parkinson’s disease: a prospective two-year follow-up study. Acta Neurologica Scandinavica. 2011;123:193–200. DOI 10.1111/j.1600-0404.2010.01386.x

Conditions: COND-PD Parkinson’s disease

Scoped audit evidence

These are source- and component-level audit summaries as of 3 October 2026. Access and comparison scope can differ by report; none certifies every result or the underlying raw data.

Parkinson’s disease — balance

Latest listed audit check, current for its stated components. Later recovery/refinement here supersedes earlier access limitations only where explicitly stated; it does not resolve unrelated source contradictions.

Complete final originalPDF independently supports revised balance P145–146/P187/P235/P306:125regionalPD,120sway,79any59recurrent,2year diaries/3-monthcalls,5withdrawn8lost,partialfollowup14.5months,ON,inclinometry. Table2precise fall-groupvelocity.64/.49 p.016,area3.5/2.1 p.011,path38.6/29.0 p.010; no eye-condition label. Groupedforwardselection retained fallhistoryOR3.02(1.23–7.44),ADL1.13(1.04–1.22). Four-year18deaths/107alive;Table2swaymortalityp.393/.166/.143;age-adjusted slowgaitOR16.28(1.85–142.97). NoAUC/calibration/validation/exposure-lengthsensitivityreported. Stand-incapablepatients excluded, and2007publicationpartofsameprogramme. Source locator: archived source evidence pp194–199,Figure1,Tables1–4; original2009thesisMethodspp51–59foradditionalstanceprotocol Limit: FinaljournalMethods refers to priorpublicationsforinclinometerprotocol; sacralrod,feet together,barefoot,armsides,2x60sec eyeconditions remainexplicitlythesis-sourced as reportstates.

Earlier audit check 1 (historical evidence record). Its access limitations are superseded wherever the latest check above explicitly closes them. Retained for the distinct components and provenance, not as a current access statement.

Balance P145–146/P187–189/P235/P306–308:thesisStudyIVconfirms125,120sway,13partialfollowup,79any/59recurrent2years,18deaths4years;inclinometry2x60sEO/ECbarefeet togetherarmsides,ON;exactunivariateswaygroupvaluesandmortalityp.393/.166/.143;finalfallsORhistory3.02(1.23–7.44),ADL1.13(1.04–1.22);ageadjustedwalkingmortality16.28(1.85–142.97). Source locator: OriginalMatinolli2009thesis pp51–59,69–74,Tables11/14; archived source evidence Limit: Final2011journalbody stillunavailable independently; thesisearlierversion corroborates listedscience butcannotprovefinaljournal table numbering/access. Protocoloriginalprimarynotinferred.

Limitations: Only scoped comparisons, not whole-paper certification.

Parkinson’s disease — balance1

Latest listed audit check, current for its stated components. Later recovery/refinement here supersedes earlier access limitations only where explicitly stated; it does not resolve unrelated source contradictions.

Complete final originalPDF independently supports revised balance P145–146/P187/P235/P306:125regionalPD,120sway,79any59recurrent,2year diaries/3-monthcalls,5withdrawn8lost,partialfollowup14.5months,ON,inclinometry. Table2precise fall-groupvelocity.64/.49 p.016,area3.5/2.1 p.011,path38.6/29.0 p.010; no eye-condition label. Groupedforwardselection retained fallhistoryOR3.02(1.23–7.44),ADL1.13(1.04–1.22). Four-year18deaths/107alive;Table2swaymortalityp.393/.166/.143;age-adjusted slowgaitOR16.28(1.85–142.97). NoAUC/calibration/validation/exposure-lengthsensitivityreported. Stand-incapablepatients excluded, and2007publicationpartofsameprogramme. Source locator: archived source evidence pp194–199,Figure1,Tables1–4; original2009thesisMethodspp51–59foradditionalstanceprotocol Limit: FinaljournalMethods refers to priorpublicationsforinclinometerprotocol; sacralrod,feet together,barefoot,armsides,2x60sec eyeconditions remainexplicitlythesis-sourced as reportstates.

Earlier audit check 1 (historical evidence record). Its access limitations are superseded wherever the latest check above explicitly closes them. Retained for the distinct components and provenance, not as a current access statement.

Balance P145–146/P187–189/P235/P306–308:thesisStudyIVconfirms125,120sway,13partialfollowup,79any/59recurrent2years,18deaths4years;inclinometry2x60sEO/ECbarefeet togetherarmsides,ON;exactunivariateswaygroupvaluesandmortalityp.393/.166/.143;finalfallsORhistory3.02(1.23–7.44),ADL1.13(1.04–1.22);ageadjustedwalkingmortality16.28(1.85–142.97). Source locator: OriginalMatinolli2009thesis pp51–59,69–74,Tables11/14; archived source evidence Limit: Final2011journalbody stillunavailable independently; thesisearlierversion corroborates listedscience butcannotprovefinaljournal table numbering/access. Protocoloriginalprimarynotinferred.

Limitations: Only scoped comparisons, not whole-paper certification.

Reports citing this source

Update record

Updating the wiki · Evidence and status guide